FDA Inspection 1204459 — South Florida Institute for Reproductive Medicine

South Florida Institute for Reproductive Medicine — FEI 3007787718

The FDA completed an inspection of South Florida Institute for Reproductive Medicine on April 19, 2023 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 19, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Naples, FL (United States)